SCHEMBL4888065

SCHEMBL4888065

CC1CCC(C(C)C)C(OC(=O)C2C(C=CCC=O)C2(C)C)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.44
EPHX1 P07099 2/20 0.43
ALDH1A1 P00352 9/20 0.42
MAPT P10636 3/20 0.42
MAPK1 P28482 3/20 0.42
HPGD P15428 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 2/20 0.37
USP2 O75604 1/20 0.37
P2RX4 Q99571 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.36
MITF O75030 1/20 0.36
TP53 P04637 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1073399 0.88 EPHX1 (0.42) CYP19A1EPHX1ALDH1A1MAPTMAPK1
SCHEMBL1073395 0.88 EPHX1 (0.42) CYP19A1EPHX1ALDH1A1MAPTMAPK1
SCHEMBL4986006 0.86 EPHX1 (0.46) CYP19A1EPHX1ALDH1A1MAPTMAPK1
SCHEMBL4986012 0.86 EPHX1 (0.46) CYP19A1EPHX1ALDH1A1MAPTMAPK1
SCHEMBL2128363 0.86 EPHX1 (0.51) CYP19A1EPHX1ALDH1A1MAPTMAPK1
SCHEMBL295262 0.83 EPHX1 (0.46) CYP19A1EPHX1ALDH1A1MAPTMAPK1
SCHEMBL294471 0.82 EPHX1 (0.45) CYP19A1EPHX1ALDH1A1MAPTMAPK1
SCHEMBL1072054 0.81 EPHX1 (0.42) CYP19A1EPHX1ALDH1A1MAPTMAPK1
SCHEMBL1072050 0.81 EPHX1 (0.42) CYP19A1EPHX1ALDH1A1MAPTMAPK1
SCHEMBL4888048 0.81 EPHX1 (0.44) CYP19A1EPHX1ALDH1A1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064898-A1 Method for Producing Oxygen-Containing Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064898-A1 Method for Producing Oxygen-Containing Compound AOC2, AOX1, CAT CYP19A1 515/4885EPHX1 321/4885ALDH1A1 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.